Although there is no evidence from previous literature to suggest that miR-1247-3p is associated with cell cycle-related proteins including cyclin D1, the miRNA may be associated with the antitumor effect of regorafenib on HCC. The gene discussed is CCND1; the disease is hepatocellular carcinoma.